Agreed. Thats the only piece of news that will not only rocket the share price but sustain it for many months. It will be the ultimate validation and there will be nothing that shorts or manipulators can do at that point. It will stop dilution as well as position the company for a buyout in another year or so.
Although, my bet is big pharma won’t inject non dilutive cash. In fact, the big pharma won’t even PR any news that includes NWBO. If such an agreement was signed (contingent on UK approval) LP wouldn’t have included the language she did in the last quarterly report. There would be no need to do this and besides big pharma wouldn’t allow such behavior. Instead LP chose to dangle a carrot. Sign of weakness!
Market Data 
Markets 
AI
